3 authorised products containing Natalizumab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Tyruko 300 mg concentrate for solution for infusion EU/1/23/1745/001 |
Natalizumab | Polpharma Biologics S.A. | โ |
| Tysabri 150 mg solution for injection in pre-filled syringe EU/1/06/346/002 |
Natalizumab | Biogen Netherlands B.V. | โ |
| Tysabri 300 mg concentrate for solution for infusion EU/1/06/346/001 |
Natalizumab | Biogen Netherlands B.V. | โ |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (โAuthorised or Transfer Pending Productsโ), licensed CC BY 4.0, refreshed daily. Regulatory information only โ not medical advice.